NO20022645L - Farmasöytisk superdisintegrerende stoff - Google Patents

Farmasöytisk superdisintegrerende stoff

Info

Publication number
NO20022645L
NO20022645L NO20022645A NO20022645A NO20022645L NO 20022645 L NO20022645 L NO 20022645L NO 20022645 A NO20022645 A NO 20022645A NO 20022645 A NO20022645 A NO 20022645A NO 20022645 L NO20022645 L NO 20022645L
Authority
NO
Norway
Prior art keywords
superdisintegrant
pharmaceutical
pharmaceutical superdisintegrant
Prior art date
Application number
NO20022645A
Other languages
English (en)
Other versions
NO20022645D0 (no
Inventor
John Nicholas Staniforth
Original Assignee
Penwest Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Penwest Pharmaceutical Co filed Critical Penwest Pharmaceutical Co
Publication of NO20022645D0 publication Critical patent/NO20022645D0/no
Publication of NO20022645L publication Critical patent/NO20022645L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
NO20022645A 1999-12-06 2002-06-05 Farmasöytisk superdisintegrerende stoff NO20022645L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16917499P 1999-12-06 1999-12-06
PCT/US2000/032989 WO2001039746A1 (en) 1999-12-06 2000-12-06 Pharmaceutical superdisintegrant

Publications (2)

Publication Number Publication Date
NO20022645D0 NO20022645D0 (no) 2002-06-05
NO20022645L true NO20022645L (no) 2002-08-01

Family

ID=22614504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022645A NO20022645L (no) 1999-12-06 2002-06-05 Farmasöytisk superdisintegrerende stoff

Country Status (11)

Country Link
US (2) US6660303B2 (no)
EP (1) EP1244428A1 (no)
KR (1) KR20020062323A (no)
AU (2) AU771440B2 (no)
BR (1) BR0016482A (no)
CA (1) CA2393231A1 (no)
HU (1) HUP0301333A3 (no)
IL (1) IL150053A0 (no)
MX (1) MXPA02005562A (no)
NO (1) NO20022645L (no)
WO (1) WO2001039746A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204771D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Fast disintegrating tablets
US20040029843A1 (en) * 2002-06-20 2004-02-12 Orapharma, Inc. Rapidly disintegrating formulations for treating or preventing mucositis
SI21221A (sl) * 2002-06-21 2003-12-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Hitro razpadljive tablete
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
AU2004296877A1 (en) * 2003-12-09 2005-06-23 Incyte Corporation Dosing methods for ss-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine antiviral therapy
DE602005008721D1 (de) * 2004-03-10 2008-09-18 Ranbaxy Lab Ltd Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
ATE378042T1 (de) * 2004-04-12 2007-11-15 Pfizer Prod Inc Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
ES2675581T3 (es) 2005-02-25 2018-07-11 Takeda Pharmaceutical Company Limited Método para producir gránulos de un compuesto de bencimidazol recubiertos
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
JP2009501801A (ja) * 2005-07-18 2009-01-22 ホライゾン セラピューティクス， インコーポレイテッド イブプロフェンとファモチジンとを含有する医薬およびその投与
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008065504A1 (en) * 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
CA2673458A1 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
EP2397161B1 (en) * 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
CN102387833B (zh) 2009-03-20 2016-01-13 因卡伯实验室有限责任公司 固体药物给药设备
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
EP3166597A2 (en) * 2014-07-11 2017-05-17 Azanta Danmark A/S Misoprostol dispersible tablet
US20160008310A1 (en) * 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
WO2021174183A1 (en) * 2020-02-27 2021-09-02 Henkel IP & Holding GmbH Encapsulated cleansing composition
CN112618503B (zh) * 2021-01-20 2022-04-15 天津市中央药业有限公司 头孢地尼分散片

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141875A (en) 1961-03-15 1964-07-21 Fmc Corp Crystallite aggregates disintegrated in acid medium
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4910023A (en) * 1988-06-09 1990-03-20 Warner-Lambert Company Drug in combination with flavor masking agent and method for making same
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
US5468286A (en) * 1989-10-25 1995-11-21 National Starch And Chemical Investment Holding Corporation Enzymatically debranched starches as tablet excipients
IT1241417B (it) 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CA2041774C (en) 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
US5215757A (en) 1991-03-22 1993-06-01 The Procter & Gamble Company Encapsulated materials
US5272191A (en) 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
PL173249B1 (pl) 1992-07-24 1998-02-27 Labopharm Inc Tabletka o kontrolowanym uwalnianiu leku
US5616343A (en) 1993-03-25 1997-04-01 Labopharm, Inc. Cross-linked amylose as a binder/disintegrant in tablets
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5948438A (en) 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6106865A (en) 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
IL139728A (en) 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet
CA2217238C (en) 1997-10-24 2005-09-20 Louis Cartilier Cross-linked cellulose as a tablet excipient

Also Published As

Publication number Publication date
AU2061401A (en) 2001-06-12
KR20020062323A (ko) 2002-07-25
CA2393231A1 (en) 2001-06-07
IL150053A0 (en) 2002-12-01
US6660303B2 (en) 2003-12-09
MXPA02005562A (es) 2004-09-10
NO20022645D0 (no) 2002-06-05
WO2001039746A1 (en) 2001-06-07
EP1244428A1 (en) 2002-10-02
AU2004202515A1 (en) 2004-07-01
BR0016482A (pt) 2002-12-24
AU771440B2 (en) 2004-03-25
HUP0301333A3 (en) 2005-06-28
HUP0301333A2 (hu) 2004-05-28
US20050100600A1 (en) 2005-05-12
US20020068084A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
NO20022645L (no) Farmasöytisk superdisintegrerende stoff
DK1637127T3 (da) Terapeutisk mikroskum
NO20021400D0 (no) Terapeutiske konazolinderivater
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
NO20015175L (no) Farmasöytisk sammensetning
DE69930152D1 (de) Projektor
IT1315260B1 (it) Bendaggio gastrico rimovibile
IS5760A (is) Meðferðarlegar bíarýl afleiður
NO20011085D0 (no) Tablett med umiddelbar frigivningsvirkning
NO20022692L (no) Terapeutiske midler
DE50001455D1 (de) Blisterverpackung
NO20022606L (no) Farmasöytiske kombinasjoner
NO20005179D0 (no) Medikament behandling
NO20014926D0 (no) Farmasöytiske forbindelser
FR2802423B1 (fr) Compositions pharmaceutiques
DE60032510D1 (de) Kondom
DE60025760D1 (de) Anisotrop-leitender film
FI4488U1 (fi) Farmaseuttinen koostumus
DK1176982T3 (da) Prucaloprid oral opløsning
IS6163A (is) Lyfjakomplex
NO20016301D0 (no) Terapeutiske midler
DE59905747D1 (de) Blisterpackung
ID26141A (id) Film rentang poliolefin
DE50007261D1 (de) Mehrschichtverbund
DE29813269U1 (de) Tablette

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application